Genes Implicated in Serotonergic and Dopaminergic Functioning Predict BMI Categories
Open Access
- 1 February 2008
- Vol. 16 (2) , 348-355
- https://doi.org/10.1038/oby.2007.65
Abstract
Objective: This study addressed the hypothesis that variation in genes associated with dopamine function (SLC6A3, DRD2, DRD4), serotonin function (SLC6A4, and regulation of monoamine levels (MAOA) ma...Keywords
This publication has 75 references indexed in Scilit:
- DRD2 genetic variation in relation to smoking and obesity in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialPharmacogenetics and Genomics, 2006
- Overweight, Obesity, and Mortality in a Large Prospective Cohort of Persons 50 to 71 Years OldNew England Journal of Medicine, 2006
- Obesity is Associated with Genetic Variants That Alter Dopamine AvailabilityAnnals of Human Genetics, 2006
- What is the best measure of adiposity change in growing children: BMI, BMI %, BMI z-score or BMI centile?European Journal of Clinical Nutrition, 2005
- Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. AdultsNew England Journal of Medicine, 2003
- Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common diseaseNature Genetics, 2003
- Association of dopamine D2 receptor polymorphisms Ser311Cys and TaqIA with obesity or type 2 diabetes mellitus in Pima IndiansInternational Journal of Obesity, 2000
- Increased prevalence of the Taq I A1allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary reportPharmacogenetics, 1996
- Brain Serotonin, Carbohydrate‐Craving, Obesity and DepressionObesity Research, 1995
- The Body-Mass Index of Twins Who Have Been Reared ApartNew England Journal of Medicine, 1990